Medical network - March 2, 2017 national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue (hereinafter referred to as "the new medical insurance directory") officially released, included the western medicine and Chinese patent medicine altogether 2535 varieties, increased by 339, 15.4%; Chinese medicine yinpian part did not make an adjustment, still continue to use the 2009 edition rules. At the same time, 45 to negotiate varieties were also determined. (see the latest blockbuster! 2017 medicare catalog 339 new breed ")
In the new medical insurance directory, in addition to expand medicare drug coverage, support basic medicine, medicine for children and the innovation medicine suffers bestow favor on the pharmaceutical industry concern. In medicine as an example, the innovation medicine is expensive medicine "pronoun", and high-priced medicines have always been the "siege" or "reject" in object, in recent years the government specially set up the medical insurance fund regulators, take many forms with the lever as health care health care, medical institutions and appeared in "medicine accounted for" "in" bargain "secondary" "two votes" system and measures such as means to malicious pressure drug prices and reduce drug consumption.
But in the end because of the heavy price and ignore the quality, curative effect is unknown or slow, drug dosage does not decrease or increase in disguised forms (medicine proportion become false) and excessive medical treatment, so, payment has not been able to significantly reduce the lower, medical insurance fund has been on the verge of overdraft, parts and even has obvious overdraft, so the government financial pressure, health care is struggling, directly affect health care reform.
So, how to achieve control fee?
Health insurance to pay one's speciality - press macro-reforms!
Can say this is health control cost is the best (or end) channels and methods. However, drugs, if there is no reliable quality and efficacy of drugs, and simple blindly to use cheap drugs or take other measures such as malicious pressure medicine proportion, zero drug addition, cancel outpatient pharmacy, etc., are difficult to ensure the patient consumption reduction, curative effect, the length of date shorten and the purpose of the treatment in pain. Even the implementation of the "two votes" and allowed to bargain "secondary", it is difficult to guarantee drug quality effect and the medical insurance fund operating steadily.
Perhaps this is the reason why according to macro-reforms shanshan and with purpose, with high sexual price is supported by the drug use to ensure that the patient exact curative effect, reduce hospitalization dates, reduce consumption, reduce the patients relieve patients "to see a doctor difficult see a doctor expensive", in order to minimize health care payments, realize the maximization of the efficiency of medical insurance fund.
But in the context of the current policy, cost-effective, the use of drugs has its specific or specialized level, is not the first, second and tertiary hospitals all have its market development. Cost of new drug research and development, so to speak, and generic drugs are used for difficult and critical illness. And reform the classification system of major initiatives and will lasting, make 3 armour hospital which crowd the main diagnosis and treatment of medical institutions, rural county is common disease frequently occurring drugs mainly supply market, high sexual price new drugs and generic drugs must also be concentrating on the market development of choice for tertiary hospitals, concentration of 3 armour hospital is particularly difficult and complicated cases.
At present, under the bound of hierarchical diagnosis and treatment according to macro-reforms has begun in medical institutions to carry out the secondary and above.
On January 16, the national development and reform commission issued "notice about push press disease to charge them.
On February 20, the ministry of finance, people club department, who planning commission jointly issued "on strengthening the basic medical insurance fund budget management give play to the role of medical insurance fund control of opinions put forward by macro-reforms;
Recently, the fujian province health department, who planning commission jointly issued by the fujian provincial public hospitals by diseases fee and payment related issues notice ", 100 kinds of unified implement according to the disease to charge;
Recently, state "on further reform and improve the use policy for producing and distributing medicines of several opinions has been clear about the medical market will be more gathered in pharmaceutical value (note that not drug price!) , based on the data of clinical and pricing will be in the market play a more and more important role in the access.
Some analysts believe that the new medical insurance directory of new drug effect can be obvious market fastest one year. On this basis, the author argues that the new medical insurance directory high price of drugs has a high development value. Pharmaceutical enterprises should in reshaping industry values, the concept of running a business to pay attention to the drug on the intrinsic value and quality, strengthen the investment in pharmaceutical research and development, take the drug quality, at the same time, should pay attention to and strengthen the cooperation with 3 armour hospital, will focus on 3 armour hospital as a cost-effective important development of new drugs and generic drugs market.
|
